Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.

Related Keywords

United States ,Kansas ,Japan ,Japanese ,Yaron Werber ,Anthony Pagano ,Tahi Ahmadi ,Asthika Goonewardene ,James Gordon ,Sachin Jain ,Judith Klimovsky ,Vikram Purohit ,Etzer Dament ,Anthony Mancini ,Pfizer ,Anthony ,Call Transcript May ,Genmab First Quarter ,Investor Relations ,Chief Operating Officer ,Chief Medical Officer ,Chief Development Officer ,Annual Meeting ,Japanese Society ,Medical Oncology ,Japan New Drug Application ,Most Money ,Thanks Vikram ,Xian Deng ,Thanks Judith ,